BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2016
View Archived Issues
Kymab and MD Anderson form immuno-oncology R&D alliance
Read More
Jubilant Biosys and Sanofi Deutschland collaborate in metabolic disorders
Read More
Memorial Sloan Kettering and Juno Therapeutics sign licensing agreement for MUC-16 binder
Read More
Dual Therapeutics and Bristol-Myers Squibb establish collaboration in cancer
Read More
Illumina launches cancer diagnostic company GRAIL
Read More
Pfizer announces investments and a research collaboration
Read More
Diffusion Pharmaceuticals completes merger with RestorGenex
Read More
FDA grants fast track designation for GC-4419
Read More
Adenoviral GDEPT combined with radiotherapy safe and effective in phase II prostate cancer study
Read More
Tobira Therapeutics initiates a program to evaluate cenicriviroc for the treatment of PSC
Read More
FDA grants orphan drug designation for WT1 cancer vaccine for the treatment of AML
Read More
Innate Pharma signs new licensing agreements with Orega, Sanofi
Read More
Mylan to codevelop six Momenta biosimilars
Read More
Medshine Discovery patents PI3Kalpha inhibitors
Read More
Cisen Pharmaceutical and Medshine Discovery report mTOR/PI3Kalpha inhibitors
Read More
Researchers attempt to find tools for early diagnosis of pancreatic cancer
Read More
Shire and Baxalta to combine
Read More
High-dose monovalent inactivated poliovirus type 2 vaccine is safe and immunogenic in infants
Read More
Theravance changes name to Innoviva
Read More
Exelixis files MAA for cabozantinib in RCC
Read More
Topical quinolone antibacterial Zebiax launched in Japan
Read More
Protagonist Therapeutics begins phase I study of PTG-100
Read More
Zogenix initiates first phase III trial of ZX-008 for Dravet syndrome
Read More
Merck KGaA agrees terms to return evofosfamide rights to Threshold Pharmaceuticals
Read More
Archexin in combination with everolimus shows promise for RCC
Read More
MabTech completes Chinese phase III trials for biosimilars STI-001 and STI-002
Read More